Karolinska Institutet Science Park
SE - 171 65
Asarina Pharma (previously Umecrine Mood) is developing novel and targeted products to treat women with severe symptoms associated with the menstrual cycle such as premenstrual dysphoric disorder (PMDD), allowing these women to remain in control of their own life.
CEO: Peter Nordkild
COO: Karin Ekberg